Toxys signs agreement with BioPartner Leiden for new laboratory
Leiden, The Netherlands. May 5, 2020 – Toxys is an innovative Dutch biotech company that develops unique animal-free laboratory tests for the safety assessment of novel medicines, chemicals, cosmetics and food. Today, Toxyssigned an agreement with BioPartner Leiden for its new laboratory facilities. In spring 2021, Toxys will relocate to the new BioPartner V laboratory building at the Leiden Bio Science Park.
Toxys is growing and rapidly expanding its in vitro chemical safety testing services. These services provide animal-free safety testing of novel medicines, chemicals and consumer products. With the ambition to further broaden its portfolio of unique in vitro toxicology assays, work on acceptance and implementation of its toxicology assays for regulatory applications and speed-up international growth comes the demand for expansion of Toxys laboratory space.
BioPartner is currently building a state-of-the-art laboratory facility with flexible labs and offices. The innovative building is constructed from recycled materials and uses natural, eco-friendly materials to provide a sustainable and inspiring working environment. The building is the perfect location for Toxys to expand its modern laboratory facilities, ready for further expansion of its specialized toxicological research services and allowing further growth of the company.
Toxys is a Dutch biotech company that offers a broad spectrum of innovative in vitro toxicology solutions. Toxys was founded in 2014 as a spin-off from the Leiden University Medical Center and has its state-of-the-art laboratory facilities located at the Leiden Bio Science Park. We are experts in the field of genetic and developmental toxicology with a focus on Mode-of-Action. We are dedicated to bring relevant information to our clients on potential human health hazards of novel and existing drugs, chemicals and other substances. Toxys is currently working with 7 of the Top10 global Pharma companies and several major chemical, cosmetics and food multinationals.
BioPartner Leiden provides office and laboratory facilities for start-up and scale-up companies that conduct research specifically aimed at developing medicines and vaccines. BioPartner offers a broad and flexible package of servicesto various life science companies at the Leiden Bio Science Park in The Netherlands. The Leiden Bio Science Park is the largest Life Science park in the Netherlands and the 5th Life Science Park in Europe. Here you can find a unique collection of companies and knowledge institutions that have led to fruitful collaborations and developments since 1984. For more information: https://biopartnerleiden.nl